End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | - | Sales 2025 * | 54.14M 74.05M | Capitalization | 89.62M 123M |
---|---|---|---|---|---|
Net income 2024 * | -56M -76.59M | Net income 2025 * | -24M -32.82M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.66 x |
P/E ratio 2024 * |
-1.52
x | P/E ratio 2025 * |
-3.89
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.91% |
Latest transcript on Cellectar Biosciences Inc
Managers | Title | Age | Since |
---|---|---|---|
James Caruso
CEO | Chief Executive Officer | 65 | 15-06-14 |
Chad Kolean
DFI | Director of Finance/CFO | 59 | 14-05-27 |
Andrei Shustov
CTO | Chief Tech/Sci/R&D Officer | - | 23-02-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Driscoll
BRD | Director/Board Member | 73 | 17-04-06 |
Douglas Swirsky
CHM | Chairman | 54 | 17-04-06 |
John Neis
BRD | Director/Board Member | 68 | 08-01-31 |
1st Jan change | Capi. | |
---|---|---|
+55.32% | 815B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+2.04% | 224B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |